Could CaMKK2 enzyme be the key to treating bipolar disorder?
A recent review published in the journal Molecular Psychiatry explores the calcium-calmodulin-dependent protein kinase kinase-2 (CaMKK2) signaling pathway as a contributor to bipolar disorder pathogenesis and key treatment target. By targeting this protein-coding enzyme, CaMKK2, which is associated with many neuronal and metabolic processes, scientists may be able to develop new treatment strategies for bipolar disorder. … Read more